Plus Therapeutics, Inc. (CNSY)
$3.52-8.09%Close
BUYCRISIS · day 1
Key stats
- Market cap
- $24M
- Avg volume
- 145.8K
- Beta
- 1.43
- 1W
- -6.38%
- 1M
- -13.09%
- 3M
- -44.13%
- YTD
- -74.64%
- vs SPY 1W
- -8.53%
- vs SPY 1M
- -14.37%
- vs SPY 3M
- -48.80%
- vs SPY YTD
- -85.06%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- NERVSELLMinerva Neurosciences, Inc.CRISISQ 4$3.97-0.25%
- AEMDSELLAethlon Medical, Inc.CRISISQ -9$0.67+1.52%
- INBXSELLInhibrx Biosciences, Inc.CRISISQ 31$82.72+0.82%
- INDPSELLIndaptus Therapeutics, Inc.CRISISQ -17$1.31+1.55%
- REPLSELLReplimune Group, Inc.RECOVERYQ 13$11.91+6.34%
- DRMASELLDermata Therapeutics, Inc.CRISISQ -28$1.08-7.69%
- MXCTSELLMaxCyte, Inc.CRISISQ 10$1.07+1.90%
- ANTXBUYAN2 Therapeutics, Inc.RECOVERYQ -8$5.58+4.30%
- RCKTSELLRocket Pharmaceuticals, Inc.CRISISQ 6$3.41+9.65%
- JSPRBUYJasper Therapeutics, Inc.CRISISQ -13$0.61-3.17%
- ZCMDBUYZhongchao Inc.CRISISQ -38$1.13+0.00%
- CLDISELLCalidi Biotherapeutics, Inc.CRISISQ -29$1.68+2.44%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
---
[VALUATION]
P/E TTM-
P/E FWD-
SECTOR PE23.58
INDUSTRY PE167.36
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
BETA1.43
Company news
Loading headlines…